Insulet Corp (MEX:PODD)
MXN 4702.68 0 (0%) Market Cap: 372.46 Bil Enterprise Value: 382.28 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 87/100

Insulet Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 04:30PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Good afternoon. Thanks, everybody, for joining us for a fireside chat session here at the UBS Global Virtual Healthcare Conference. I'm Matt Taylor, the U.S. medical supplies and devices analyst for UBS. And I'm really pleased to be joined by management from the Insulet Corporation. Today, we have a few members of the management team, including Wayde McMillan, who's the EVP and Chief Financial Officer and Treasurer of the company. We also got Bret Christensen, EVP and Chief Commercial Officer. And Deb Gordon, VP and Head of the Investor Relations function. So thanks, everybody, for joining us today.

So a couple of points on this session. We're going to have a 40-minute fireside chat. If you have any questions, you want me to ask, just send them to me via e-mail or through the webcast, if I'm not hitting on anything you want to cover.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot